These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3020442)

  • 61. [Calcium antagonists in the treatment of moderate arterial hypertension].
    Mazur NA; Titov VN; Nazerov EA; Iudaev AE
    Kardiologiia; 1989 Nov; 29(11):125-8. PubMed ID: 2693795
    [No Abstract]   [Full Text] [Related]  

  • 62. Calcium channel blockers: a pathophysiologically based antihypertensive treatment concept for the future?
    Bühler FR; Hulthén L
    Eur J Clin Invest; 1982 Feb; 12(1):1-3. PubMed ID: 6279410
    [No Abstract]   [Full Text] [Related]  

  • 63. [Effect of calcium channel blockers and angiotensin I converting enzyme inhibitors on the kidney].
    Wiecek A
    Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1115-7. PubMed ID: 1305740
    [No Abstract]   [Full Text] [Related]  

  • 64. Nifedipine and other calcium channel blockers.
    Pahor M
    Eur Heart J; 1997 Jan; 18(1):168. PubMed ID: 9049532
    [No Abstract]   [Full Text] [Related]  

  • 65. Calcium entry blockers: uses and implications for anesthesiologists.
    Reves JG; Kissin I; Lell WA; Tosone S
    Anesthesiology; 1982 Dec; 57(6):504-18. PubMed ID: 6756213
    [No Abstract]   [Full Text] [Related]  

  • 66. Calcium antagonists into the nineties: appraisal and future trends. Verapamil satellite symposium to the 25th anniversary International Symposium on Calcium Antagonists. Basel, Switzerland, February 12, 1988.
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S1-82. PubMed ID: 2475675
    [No Abstract]   [Full Text] [Related]  

  • 67. Calcium antagonists in the treatment of arterial hypertension in the elderly.
    Nicita-Mauro V
    Am J Nephrol; 1986; 6 Suppl 1():115-9. PubMed ID: 3548357
    [No Abstract]   [Full Text] [Related]  

  • 68. Successful management of refractory hypertension with dual calcium channel blocker therapy: case presentation.
    Geurian K; Lipschitz D
    Arch Fam Med; 1997; 6(5):503-5; discussion 506. PubMed ID: 9305698
    [No Abstract]   [Full Text] [Related]  

  • 69. Hypoglycemia associated with the administration of angiotensin-converting enzyme inhibitor in a diabetic hemodialysis patient.
    Washio M; Onoyama K; Makita Y; Fujishima M; Fujimi S
    Nephron; 1991; 59(2):341-2. PubMed ID: 1956507
    [No Abstract]   [Full Text] [Related]  

  • 70. Angiotensin converting enzyme inhibitors: drug interactions.
    Hodsman GP; Johnston CI
    J Hypertens; 1987 Feb; 5(1):1-6. PubMed ID: 3035008
    [No Abstract]   [Full Text] [Related]  

  • 71. Calcium antagonists in systemic hypertension: focus on verapamil. Concluding remarks. Part I.
    Laragh JH
    Am J Cardiol; 1986 Feb; 57(7):87D-89D. PubMed ID: 3953431
    [No Abstract]   [Full Text] [Related]  

  • 72. [Gynecomastia (of the adult)].
    Kolyvanos Naumann U; Suter PM; Käser L; Vetter W
    Praxis (Bern 1994); 2005 Jun; 94(22):903-8; quiz 909. PubMed ID: 15986635
    [No Abstract]   [Full Text] [Related]  

  • 73. Obsessive-compulsive disorder: cerebral calcium deficiency as a possible etiologic/pathogenetic factor--a case study.
    Oken RJ
    Med Hypotheses; 1997 Dec; 49(6):513-4. PubMed ID: 9466376
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Effect of isoptin on the microcirculation of hypertension patients].
    Agapova EN; Denisova TP; Eliseeva LN
    Kardiologiia; 1984 May; 24(5):101-2. PubMed ID: 6748461
    [No Abstract]   [Full Text] [Related]  

  • 75. Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension.
    Waller PC; McInnes GT
    Br Med J (Clin Res Ed); 1987 Mar; 294(6574):769. PubMed ID: 3032326
    [No Abstract]   [Full Text] [Related]  

  • 76. Advances in therapeutics: converting enzyme inhibition and the kidney.
    Hollenberg NK
    Am J Med; 1985 Sep; 79(3C):1-2. PubMed ID: 2996340
    [No Abstract]   [Full Text] [Related]  

  • 77. Vaccine takes aim at hypertension.
    Mitka M
    JAMA; 2007 Dec; 298(24):2854-5. PubMed ID: 18159049
    [No Abstract]   [Full Text] [Related]  

  • 78. [Calcium channel blockers and angiotensin converting enzyme inhibitors in the treatment of high blood pressure].
    Koster M
    Ned Tijdschr Geneeskd; 1986 Aug; 130(34):1509-13. PubMed ID: 3020442
    [No Abstract]   [Full Text] [Related]  

  • 79. [New therapeutic approaches to arterial hypertension].
    Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1982 Sep; 112(39):1330-4. PubMed ID: 6755692
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Hypertension treatment 1985: significance of calcium antagonists and angiotensin-converting enzyme inhibitors].
    Weidmann P
    Ther Umsch; 1985 Aug; 42(8):528-39. PubMed ID: 2996166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.